按类型、工具和地区分類的计算生物学市场

计算生物学市场在 2025 年的价值估计为 91.3 亿美元，预计到 2032 年将达到 284 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 17.6%。

计算生物学旨在透过开发疾病的计算模型、使用患者数据对这些模型进行个人化设定以及应用这些模型来改善疾病的诊断和治疗，从而改善医疗保健。这些患者模型用于发现新的风险生物标记、预测疾病进展、设计最佳治疗方法以及识别癌症、心血管疾病和神经系统疾病等应用中的新药物标靶。患者特异性定量模型的开发和应用可用于理解、诊断和治疗疾病。计算医学可用于分子医学、生理医学和解剖医学。透过整合生物医学讯号处理、计算建模、机器学习和健康资讯学，可以利用电子健康记录、生理时间序列资料和基因组学开发个人化医疗的新方法。

市场动态

预计主要市场参与企业不断增加的新产品发布、併购将推动全球计算生物学市场的成长。例如，2022 年 7 月 25 日，美国基因组编写公司 Replay 筹集了 5,500 万美元的种子资金。此轮融资由 KKR 和 OMX Ventures主导，ARTIS Ventures、Lansdowne Partners、SALT、DeliBio Ventures 和 Axial 参投。 Replay 的基因组医学套件包包括一系列用于编写和递送大型 DNA 片段的颠覆性平台技术，包括高有效载荷容量的 HSV 递送平台、低免疫抗原性细胞疗法平台和专有基因组编写平台。美国基因组编写公司 Replay 解决了目前限制临床进展的挑战，包括提高有效载荷容量；降低商品成本的现成细胞疗法；提高生产速度、产量和一致性；以及扩展基因组工程能力。

本次调查的主要特点

• 本报告对全球计算生物学市场进行了详细分析，展示了预测期 2025 年至 2032 年的市场规模（十亿美元）和年复合成长率（CAGR），以 2024 年为基准年。
• 它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
• 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数概述了全球计算生物学市场的主要企业。
• 本研究涉及的主要企业包括 Accelrys、Certara、LP、Chemical Computing Group Inc.、Compugen、Ltd.、Entelos、Inc. (Rosa & Co. LLC)、Genedata AG、Insilico BIoTechnology AG、Leadscope、Inc.、Nimbus Discovery LLC、Rhenovia ology AG、Leadscope、Inc.、Nimbus Discovery LLC、Rhenovia ology AG、Leadscope、Inc.、Nimbus Discovery LLC、Rhenovia ology AG.
• 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、最新策略、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 相关人员可以透过用于全球计算生物学市场分析的各种策略矩阵更轻鬆地做出决策。

目录

第一章：调查目标和先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图（COM）

第三章：市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 抑制因素
  • 市场机会
• 影响分析
• 最新产品发布
• 流行病学
• 合併、收购与合作
• 监管情景
• PEST分析

4. 全球计算生物学市场（按类型），2020 年至 2032 年

• 介绍
• 细胞与生物模拟
• 计算基因组学
• 计算蛋白质体学
• 药物基因组学
• 其他（转录组学/代谢体学）
• 疾病建模与模拟应用
• 药物研发
• 药物开发

5. 2020 年至 2032 年全球计算生物学市场（依工具划分）

• 介绍
• 内容/资料库
• 分析软体和服务
• IT基础设施（硬体）

6. 2020 年至 2032 年全球计算生物学市场（按地区）

• 介绍
• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 东南亚国协
  • 澳洲
  • 韩国
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 北非
  • 中部非洲
  • 南非

第七章 竞争态势

• Accelrys
• Certara, LP
• Chemical Computing Group Inc.
• Compugen, ltd.
• Entelos, Inc.（Rosa and Co. LLC）
• Genedata AG
• Insilico BIoTechnology AG
• Leadscope, Inc.
• Nimbus Discovery LLC
• Rhenovia Pharma SAS
• Schrodinger
• Simulation Plus, Inc.

第 8 章 章节

• 调查方法
• 关于出版商

Computational Biology Market is estimated to be valued at USD 9.13 Bn in 2025 and is expected to reach USD 28.4 Bn by 2032, growing at a compound annual growth rate (CAGR) of 17.6% from 2025 to 2032.

Computational biology aims to advance healthcare by developing computational models of diseases, personalizing these models using data from patients, and applying these models to improve the diagnosis and treatment of diseases. These patient models are used to discover novel risk biomarkers, predict disease progression, design optimal treatments, and identify new drug targets for applications such as cancer, cardiovascular disease, and neurological disorders. The development and application of patient-specific, quantitative models can be used to understand, diagnose, and treat disease. Computational medicines can be used for molecular, physiological, and anatomical medicines. The integration of biomedical signal processing, computational modeling, machine learning, and health informatics can be done to develop new approaches in personalized medicine via electronic health records, physiological time series data, and genomics.

Market Dynamics

The increasing launch of new products, mergers, and acquisitions by key market players is expected to drive the global computational biology market growth. For instance, on July 25, 2022, Replay, a U.S.-based genome writing company, received US$ 55 million in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, and a proprietary genome writing platform. The Replay, a U.S.-based genome writing company solves challenges in currently limiting clinical progress including increased payload capacity, off the shelf cell therapies that can reduce the cost of goods, improve production speed, volume and consistency, and expand the potential for genome engineering.

Key features of the study

• This report provides an in-depth analysis of the global computational biology market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global computational biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• The key companies covered as a part of this study include Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global computational biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global computational biology market.

Market Segmentation

• Global Computational Biology Market, By Type
  • Cellular and Biological Simulation
  • Computational Genomics
  • Computational Proteomics
  • Pharmacogenomics
  • Others (Transcriptomics/Metabolomic)
  • Disease Modeling and Simulation Applications
  • Drug Discovery
  • Drug Development
• Global Computational Biology Market, By Tools
  • Content/Database
  • Analysis Software and Services
  • IT Infrastructure (Hardware)
• Global Computational Biology Market, By Region
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa
• Company Profiles
  • Accelrys
  • Certara, L.P.
  • Chemical Computing Group Inc.
  • Compugen, ltd.
  • Entelos, Inc. (Rosa & Co. LLC)
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc.
  • Nimbus Discovery LLC
  • Rhenovia Pharma SAS
  • Schrodinger
  • Simulation Plus, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Tools
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Recent Product Launches
• Epidemiology
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis

4. Global Computational Biology Market, By Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Cellular and Biological Simulation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Computational Genomics
• Computational Proteomics
• Pharmacogenomics
• Others (Transcriptomics/Metabolomic)
• Disease Modeling and Simulation Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Drug Discovery
• Drug Development

5. Global Computational Biology Market, By Tools, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021-2032
  • Segment Trends
• Content/Database
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Analysis Software and Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• IT Infrastructure (Hardware)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Computational Biology Market, By Region, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Tools, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

• Accelrys
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Certara, L.P.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Chemical Computing Group Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Compugen, ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Entelos, Inc. (Rosa and Co. LLC)
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Genedata AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Insilico Biotechnology AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Leadscope, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nimbus Discovery LLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Rhenovia Pharma SAS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Schrodinger
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Simulation Plus, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

8. Section

• Research Methodology
• About Us